Quick Answer
GENTEX CORP reported Total Revenue of $2.53 billion for fiscal year 2025.
GENTEX CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.53B +9.6% |
$2.31B +0.6% |
$2.30B +19.8% |
$1.92B +10.8% |
$1.73B +2.5% |
$1.69B -9.2% |
| Revenue (ASC 606) | $2.53B +9.6% |
$2.31B +0.6% |
$2.30B +19.8% |
$1.92B +10.8% |
$1.73B +2.5% |
$1.69B -9.2% |
| Net Income | $384.84M -4.9% |
$404.49M -5.6% |
$428.40M +34.4% |
$318.76M -11.7% |
$360.80M +3.8% |
$347.56M -18.2% |
| Diluted EPS | $1.74 -1.1% |
$1.76 -4.3% |
$1.84 +35.3% |
$1.36 -9.3% |
$1.50 +6.4% |
$1.41 -15.1% |
| Total Assets | $2.93B +6.1% |
$2.76B +5.7% |
$2.61B +12.2% |
$2.33B +9.2% |
$2.13B -3.0% |
$2.20B +1.3% |
| Cash and Equivalents | $145.65M -37.6% |
$233.32M +3.0% |
$226.44M +5.4% |
$214.75M -18.1% |
$262.31M -38.0% |
$423.37M +42.9% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $2.49B +0.8% |
$2.47B +6.7% |
$2.31B +11.9% |
$2.07B +6.6% |
$1.94B -1.3% |
$1.96B +1.3% |
| R&D Expense | $203.26M +12.0% |
$181.48M +17.6% |
$154.36M +15.8% |
$133.31M +13.2% |
$117.76M +1.6% |
$115.94M +1.1% |
| Operating Income | $473.94M +3.1% |
$459.73M -7.3% |
$495.73M +34.0% |
$370.01M -9.7% |
$409.78M +2.6% |
$399.56M -18.2% |
| Gross Profit | $866.71M +12.4% |
$771.09M +1.1% |
$762.63M +25.1% |
$609.81M -1.6% |
$619.71M +2.4% |
$605.44M -12.0% |
| Shares Outstanding | 215.45M -5.2% |
227.21M -1.8% |
231.46M -1.2% |
234.17M -1.0% |
236.44M -3.0% |
243.69M -3.0% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $655.24M | +7.7% | -0.4% |
| Revenue (ASC 606) | September 30, 2025 | $655.24M | +7.7% | -0.4% |
| Net Income | September 30, 2025 | $100.97M | -17.6% | +5.1% |
| Diluted EPS | September 30, 2025 | $0.46 | -13.2% | +7.0% |
| Total Assets | September 30, 2025 | $2.94B | +7.4% | +4.4% |
| Cash and Equivalents | September 30, 2025 | $178.59M | -0.6% | +49.1% |
| Long-Term Debt | September 30, 2017 | $0.00 | -100.0% | -100.0% |
| Stockholders Equity | September 30, 2025 | $2.50B | +3.2% | +2.7% |
| R&D Expense | September 30, 2025 | $52.63M | +9.1% | +2.3% |
| Operating Income | September 30, 2025 | $122.33M | -2.7% | +3.2% |
| Gross Profit | September 30, 2025 | $225.17M | +10.3% | -0.1% |
- GENTEX CORP reported Total Revenue of $2.53 billion for fiscal year 2025.
- GENTEX CORP showed an increase of +9.6% in Total Revenue compared to the prior fiscal year.
- GENTEX CORP reported Revenue (ASC 606) of $2.53 billion for fiscal year 2025.
- GENTEX CORP showed an increase of +9.6% in Revenue (ASC 606) compared to the prior fiscal year.
- GENTEX CORP reported Net Income of $384.84 million for fiscal year 2025.
- GENTEX CORP showed a decrease of -4.9% in Net Income compared to the prior fiscal year.
- GENTEX CORP reported Diluted EPS of $1.74 per share for fiscal year 2025.
- GENTEX CORP showed a decrease of -1.1% in Diluted EPS compared to the prior fiscal year.
- GENTEX CORP reported Total Assets of $2.93 billion for fiscal year 2025.
- GENTEX CORP showed an increase of +6.1% in Total Assets compared to the prior fiscal year.
- GENTEX CORP reported Cash and Equivalents of $145.65 million for fiscal year 2025.
- GENTEX CORP showed a decrease of -37.6% in Cash and Equivalents compared to the prior fiscal year.
- GENTEX CORP reported Long-Term Debt of $0.00 for fiscal year 2017.
- GENTEX CORP showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- GENTEX CORP reported Stockholders Equity of $2.49 billion for fiscal year 2025.
- GENTEX CORP showed an increase of +0.8% in Stockholders Equity compared to the prior fiscal year.
- GENTEX CORP reported R&D Expense of $203.26 million for fiscal year 2025.
- GENTEX CORP showed an increase of +12.0% in R&D Expense compared to the prior fiscal year.
- GENTEX CORP reported Operating Income of $473.94 million for fiscal year 2025.
- GENTEX CORP showed an increase of +3.1% in Operating Income compared to the prior fiscal year.
- GENTEX CORP reported Gross Profit of $866.71 million for fiscal year 2025.
- GENTEX CORP showed an increase of +12.4% in Gross Profit compared to the prior fiscal year.
- GENTEX CORP reported Shares Outstanding of 215.45 million shares for fiscal year 2025.
- GENTEX CORP showed a decrease of -5.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: